Quarry LP’s Arcutis Biotherapeutics ARQT Stock Holding History

Quarry LP’s Portfolio ARQT Stock Details ARQT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15K	Buy	+82	New	+$1.91K	﹤0.01%	1592
2026 Q1	–	Sell	-1,200	Closed	-$34.8K	–	1435
2025 Q4	$34.8K	Sell	1,200 -954	-44%	-$24.4K	0.01%	761
2025 Q3	$40.6K	Sell	2,154 -10,436	-83%	-$165K	0.01%	958
2025 Q2	$177K	Buy	12,590 +6,090	+94%	+$85.4K	0.04%	384
2025 Q1	$102K	Sell	6,500 -8,500	-57%	-$120K	0.02%	511
2024 Q4	$209K	Buy	+15,000	New	+$164K	0.03%	242
2024 Q2	–	Sell	-17,000	Closed	-$168K	–	1792
2024 Q1	$168K	Buy	17,000 +14,000	+467%	+$104K	0.03%	193
2023 Q4	$9.69K	Hold	3,000	–	–	﹤0.01%	1082
2023 Q3	$15.9K	Buy	+3,000	New	+$25.5K	﹤0.01%	773

Other funds holding ARQT

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quarry LP's ARQT Position: Q2 2026 in Review

Quarry LP opened a new position in Arcutis Biotherapeutics (ARQT) in Q2 2026: 82 shares worth $2.15K. The stake represents ﹤0.01% of the portfolio and ranks #1592 among its holdings. This is a return to the name: Quarry LP previously reported a position in ARQT as recently as Q4 2025.

Quarry LP first reported a position in ARQT in Q3 2023 and has held it in 9 quarters since. The position peaked at $209K in Q4 2024. 273 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

Quarry LP held 82 shares of Arcutis Biotherapeutics worth $2.15K as of Q2 2026.
Arcutis Biotherapeutics was a new Quarry LP position in Q2 2026.
Arcutis Biotherapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1592 holding.
Quarry LP first reported a position in Arcutis Biotherapeutics in Q3 2023 and has held it in 9 quarters since.
Quarry LP's Arcutis Biotherapeutics position peaked at $209K in Q4 2024.
273 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.